Interleukin-27 is abrogated in gastric cancer, but highly expressed in other Helicobacter pylori-associated gastroduodenal diseases
Helicobacter Nov 18, 2019
Rocha GA, et al. - Since there is a specific link between the IL-23/Th17 axis in cancer development and IL-27 was considered a potential cancer treatment, researchers evaluated the gastric and serum concentrations of IL-27 in two mutually exclusive Helicobacter pylori-associated diseases, gastric cancer (GC) and duodenal ulcer (DU). One hundred ten H pylori-positive patients and 40 healthy blood donors were prospectively studied. According to results, IL-27 was not detected in patients with GC, but in patients with DU, cytokine concentration was very high. In addition, IL-27 was detected in the gastritis patients and in the H pylori-positive blood donors. Findings suggested a positive association of gastric IL-27 concentrations with an increased degree of mononuclear and polymorphonuclear cells on the antral gastric mucosa of DU patients in consonance with the DU gastritis pattern. While IL-27 and IL-27Rα secretion can be caused by H pylori infection, DU and GC have diametrically opposed cytokine patterns.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries